Skip to content
Screener

Ginkgo Bioworks DNA Gross Profit

Gross Profit at other companies

TEC
Bio-TechneTECH
$208.29M-2.9%
Revvity logo
RevvityRVTY
$416.87M+6.2%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$137.2M+85.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$1.21M+341%
Danaher logo
DanaherDHR
$3.61B+2.5%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.0%
Enterprise value$752.73M-14.6%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%—
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity1×+0.3×
Current ratio4.6×-0.8×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

$20.2Mtotal revenue−$1.7Mtotal cost of revenue=$18.44M

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298

FAQ

What is Ginkgo Bioworks's gross profit?
Ginkgo Bioworks (DNA) reported gross profit of $18.44M in Q2 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Ginkgo Bioworks's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude